Economic Models of Colorectal Cancer Screening in Average-Risk Adults

Workshop Summary

National Research Council, Institute of Medicine, Policy and Global Affairs, Technology Board on Science and Economic Policy, National Cancer Policy Board (Autoren)

Buch | Hardcover

308 Seiten

2005
National Academies Press (Verlag)
978-0-309-38794-1 (ISBN)

Infos

The National Cancer Policy Board and the Board on Science, Engineering, and Economic Policy convened a workshop in January 2004 on "Economic Models of Colorectal Cancer (CRC) Screening in Average-Risk Adults". The purpose of the workshop was to explore the reasons for differences among leading cost-effectiveness analysis (CEA) models of CRC screening, which public health policy makers increasingly rely on to help them sift through the many choices confronting them. Participants discussed the results of a collaborative pre-workshop exercise undertaken by five research teams that have developed and maintained comprehensive models of CRC screening in average-risk adults, to gain insight into each model's structure and assumptions and possible explanations for differences in their published analyses. Workshop participants also examined the current state of knowledge on key inputs to the models with a view toward identifying areas where further research may be warranted. This document summarized the presentations and discussion at the workshop.Table of Contents


Front Matter
Workshop Summary
References
Appendix A Workshop Agenda: Economic Models of Colorectal Cancer Screening in Average-Risk Adults
Appendix B Workshop Participants
Appendix C Workshop Speaker and Staff Biographies
Appendix D Overview of Harvard Model--Karen M. Kuntz, ScD.
Appendix E Description of the Laudabaum Colorectal Cancer Screening Model--Uri Ladabaum, M.D., M.S.
Appendix F MISCAN-colon: An Overview--Marjolein van Ballegooijen, Iris Vogelaar, Rob Boer, Franka Loeve, Ann Zauber, Gerrit van Oortmar, and Dik Habbema
Appendix G The Vanderbilt Colorectal Cancer Model--R.M. Ness, R.W. Klein, R.S. Dittus
Appendix H Overview of the Vijan Colorectal Cancer Screening Model--Sandeep Vijan, M.D., M.S.
Appendix I Cost-Effectiveness Analyses of Colorectal Cancer Screening: Results from a Pre-conference Modeling Exercise--Michael Pignone, M.D.,
Appendix J Recent Findings on Test Performance--Brian P. Mulhall, M.D., M.P.H.
Appendix K Cost Issues in Cost Effectiveness Modeling of Colorectal Cancer Screening--Martin L. Brown, Ph.D.
Appendix L Current Evidence on Compliance --Sally W. Vernon, M.A., Ph.D.
Appendix M Recent Trends in Follow-up Surveillance in Medicare Beneficiaries--Todd Anderson, M.S.
Appendix N Preliminary Results from CDC
Appendix O Colorectal Cancer Surveillance Testing After Polypectomy--Deborah Schrag, M.D., M.P.H.
Appendix P Natural History of Colorectal Adenomas and Cancer--T. R. Levin, M.D.
Appendix Q CISNET—Cancer Intervention and Surveillance--Eric J. (Rocky) Feuer, Ph.D.

Inhalt

1 Front Matter; 2 Workshop Summary; 3 References; 4 Appendix A Workshop Agenda: Economic Models of Colorectal Cancer Screening in Average-Risk Adults; 5 Appendix B Workshop Participants; 6 Appendix C Workshop Speaker and Staff Biographies; 7 Appendix D Overview of Harvard Model--Karen M. Kuntz, ScD; 8 Appendix E Description of the Laudabaum Colorectal Cancer Screening Model--Uri Ladabaum, M.D., M.S; 9 Appendix F MISCAN-colon: An Overview--Marjolein van Ballegooijen, Iris Vogelaar, Rob Boer, Franka Loeve, Ann Zauber, Gerrit van Oortmar, and Dik Habbema; 10 Appendix G The Vanderbilt Colorectal Cancer Model--R.M. Ness, R.W. Klein, R.S. Dittus; 11 Appendix H Overview of the Vijan Colorectal Cancer Screening Model--Sandeep Vijan, M.D., M.S; 12 Appendix I Cost-Effectiveness Analyses of Colorectal Cancer Screening: Results from a Pre-conference Modeling Exercise--Michael Pignone, M.D.,; 13 Appendix J Recent Findings on Test Performance--Brian P. Mulhall, M.D., M.P.H; 14 Appendix K Cost Issues in Cost Effectiveness Modeling of Colorectal Cancer Screening--Martin L. Brown, Ph.D; 15 Appendix L Current Evidence on Compliance --Sally W. Vernon, M.A., Ph.D; 16 Appendix M Recent Trends in Follow-up Surveillance in Medicare Beneficiaries--Todd Anderson, M.S; 17 Appendix N Preliminary Results from CDC; 18 Appendix O Colorectal Cancer Surveillance Testing After Polypectomy--Deborah Schrag, M.D., M.P.H; 19 Appendix P Natural History of Colorectal Adenomas and Cancer--T. R. Levin, M.D; 20 Appendix Q CISNET-Cancer Intervention and Surveillance--Eric J. (Rocky) Feuer, Ph.D

Produkt-Details

• Verlagsort: Washington
• Sprache: englisch
• Maße: 216 x 279 mm
• Themenwelt: Medizin / Pharmazie ► Medizinische Fachgebiete ► Onkologie
• ISBN-10: 0-309-38794-9 / 0309387949
• ISBN-13: 978-0-309-38794-1 / 9780309387941
• Zustand: Neuware